These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19225353)

  • 41. Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
    Soltau JB
    J Glaucoma; 2004 Aug; 13(4):348; author reply 348. PubMed ID: 15226666
    [No Abstract]   [Full Text] [Related]  

  • 42. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G; Bozkurt B; Irkec M
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of eye drops dispensing and dose variability by using plastic dropper tips.
    Sklubalová Z; Zatloukal Z
    Drug Dev Ind Pharm; 2006 Feb; 32(2):197-205. PubMed ID: 16537200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should patients choose their own eyedrops?
    Buller A; Hercules BL
    Acta Ophthalmol Scand; 2006 Feb; 84(1):150-1. PubMed ID: 16445459
    [No Abstract]   [Full Text] [Related]  

  • 45. Topical estrogen drops may be a new alternative in the treatment of glaucoma.
    Ozcura F; Aydin S
    Med Hypotheses; 2007; 69(2):456. PubMed ID: 17222989
    [No Abstract]   [Full Text] [Related]  

  • 46. A clinician's guide to the assessment and management of nonadherence in glaucoma.
    Budenz DL
    Ophthalmology; 2009 Nov; 116(11 Suppl):S43-7. PubMed ID: 19837260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical estrogen drops for glaucoma? A long way to go.
    Yin H; Liu X
    Med Hypotheses; 2008; 70(5):1069. PubMed ID: 18178012
    [No Abstract]   [Full Text] [Related]  

  • 48. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of eyedrops in glaucoma: how can we help to reduce non-compliance?
    Chawla A; McGalliard JN; Batterbury M
    Acta Ophthalmol Scand; 2007 Jun; 85(4):464. PubMed ID: 17286557
    [No Abstract]   [Full Text] [Related]  

  • 50. Classification of plastic eye dropper tips using Harkins and Brown's factor.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2007 Oct; 62(10):750-5. PubMed ID: 18236779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostaglandin analogs may aggravate myopic regression after laser in situ keratomileusis.
    Nowroozzadeh MH
    Am J Ophthalmol; 2009 Apr; 147(4):754; author reply 754-5. PubMed ID: 19327446
    [No Abstract]   [Full Text] [Related]  

  • 52. A model for quantifying difficulty in squeezing eyedrops from their containers.
    Nesher R; Ezra-Nimni O; Shumla E; Gur J; Hamisha S; Nesher G
    Arch Ophthalmol; 2007 Aug; 125(8):1114-7. PubMed ID: 17698760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A method of drop administration.
    Morlet N; Kelly M; Morlet GC
    Ophthalmic Surg Lasers; 1997 Aug; 28(8):687-9. PubMed ID: 9269003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contact lenses for drug delivery.
    Ciolino JB; Dohlman CH; Kohane DS
    Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Studies on ocular pharmacodynamics and pharmaceutics---Part 2: How best to apply topical ocular medication (author's transl)].
    Hu DN
    Zhonghua Yan Ke Za Zhi; 1980 Feb; 16(1):6-9. PubMed ID: 6788496
    [No Abstract]   [Full Text] [Related]  

  • 56. [New systems of drug administration through a topical ocular administration approach].
    Herrero Vanrell R
    Arch Soc Esp Oftalmol; 2001 Mar; 76(3):143-4. PubMed ID: 11283777
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
    Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of preservatives in anti-glaucoma agents on the ocular surface].
    Potop V
    Oftalmologia; 2009; 53(2):92-6. PubMed ID: 19697847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Compliance in glaucoma].
    Stefan C; Dumitrică DM
    Oftalmologia; 2008; 52(3):7-9. PubMed ID: 19149111
    [No Abstract]   [Full Text] [Related]  

  • 60. [Glaucoma--strategy of treatment].
    Stefan C; Selaru D; Stefaniu I; Dumitrică DM
    Oftalmologia; 2008; 52(3):3-6. PubMed ID: 19149110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.